Tag: TIGIT as a cancer therapy target

iTeos and GSK Lung Cancer Drug Shows Promising Response, Highlighting TIGIT as TargetA groundbreaking immunotherapy developed by iTeos Therapeutics and GSK has shown remarkable response rates in patients with a specific type of lung...